Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease

NCT06579703 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Sickle Cell Crisis
Veno-occlusive Disease

Interventions

DRUG: Ketorolac

Sponsor

Children's Blood and Cancer Center at Dell Children's Medical Center